Resource Center

Russia to roll out its first approved Covid-19 drug next week

Read more

Glenmark to begin phase III trial of COVID-19 drug combination in India 

A month ago, Glenmark Pharmaceuticals became the first organization in the country to get a nod from drug regulator DCGI to conduct Favipiravir clinical trials against COVID-19. Last week, Strides Pharma Science Ltd also announced the receival of approval from DCGI to conduct clinical trials of favipiravir on COVID-19 patients. 
Read more

First Patient Tested in UK Vaccine Trial

The first patient has been tested with a vaccine for COVID-19 in the UK. Two volunteers were injected as part of an 800 volunteer study in Oxford.
Read more

Low COVID-19 death-rates reported in India

India, the world’s second-most populous nation, is reporting lower than expected numbers ofboth infection and deaths caused by the current pandemic.
Read more

WHO warns that individuals who have recovered from COVID-19 are not necessarily Immune to reinfection

The world health organization announced that there is no scientific evidence to prove that patients who have recovered from the coronavirus are immune to reinfection in the future.
Read more